DAEWON Chemical Past Earnings Performance
Past criteria checks 0/6
DAEWON Chemical's earnings have been declining at an average annual rate of -58.9%, while the Chemicals industry saw earnings growing at 7.9% annually. Revenues have been growing at an average rate of 0.8% per year.
Key information
-58.9%
Earnings growth rate
-58.9%
EPS growth rate
| Chemicals Industry Growth | 13.9% |
| Revenue growth rate | 0.8% |
| Return on equity | -30.6% |
| Net Margin | -13.4% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
DAEWON Chemical Co., Ltd.'s (KRX:024890) Business Is Yet to Catch Up With Its Share Price
Jun 26
DAEWON Chemical's (KRX:024890) Returns On Capital Not Reflecting Well On The Business
Mar 25Investors In DAEWON Chemical Co., Ltd. (KRX:024890) Should Consider This, First
Feb 25Does DAEWON Chemical (KRX:024890) Have A Healthy Balance Sheet?
Jan 30What Type Of Returns Would DAEWON Chemical's(KRX:024890) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Jan 04
Returns On Capital At DAEWON Chemical (KRX:024890) Paint An Interesting Picture
Dec 09Revenue & Expenses Breakdown
How DAEWON Chemical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 109,645 | -14,664 | 24,022 | 1,366 |
| 31 Mar 24 | 114,676 | -12,081 | 19,781 | 1,443 |
| 31 Dec 23 | 122,178 | -9,745 | 17,336 | 1,509 |
| 30 Sep 23 | 131,612 | -13,186 | 19,781 | 1,538 |
| 30 Jun 23 | 139,265 | -11,110 | 20,183 | 1,638 |
| 31 Mar 23 | 145,068 | -9,403 | 21,483 | 1,645 |
| 31 Dec 22 | 146,805 | -9,632 | 21,632 | 1,665 |
| 30 Sep 22 | 144,411 | -5,587 | 22,783 | 1,565 |
| 30 Jun 22 | 131,801 | -7,184 | 21,612 | 1,621 |
| 31 Mar 22 | 120,734 | -7,673 | 20,883 | 1,505 |
| 31 Dec 21 | 113,339 | -7,006 | 19,949 | 1,474 |
| 30 Sep 21 | 111,400 | -2,329 | 15,160 | 1,368 |
| 30 Jun 21 | 110,945 | -1,661 | 15,073 | 1,257 |
| 31 Mar 21 | 105,162 | -3,577 | 14,127 | 1,507 |
| 31 Dec 20 | 108,787 | -2,175 | 14,600 | 1,708 |
| 30 Sep 20 | 111,975 | 984 | 12,601 | 1,922 |
| 30 Jun 20 | 120,934 | 3,047 | 13,008 | 1,928 |
| 31 Mar 20 | 133,539 | 5,412 | 15,744 | 1,750 |
| 31 Dec 19 | 133,053 | 5,867 | 15,654 | 1,524 |
| 30 Sep 19 | 130,306 | 2,195 | 18,562 | 1,363 |
| 30 Jun 19 | 126,512 | 1,549 | 17,889 | 1,630 |
| 31 Mar 19 | 119,903 | 2,021 | 14,694 | 1,608 |
| 31 Dec 18 | 114,627 | 1,083 | 14,056 | 1,767 |
| 30 Sep 18 | 114,848 | 2,903 | 13,488 | 1,864 |
| 30 Jun 18 | 115,121 | 1,654 | 13,693 | 1,592 |
| 31 Mar 18 | 114,949 | 1,456 | 14,007 | 1,877 |
| 31 Dec 17 | 118,379 | 1,586 | 14,167 | 1,939 |
| 30 Sep 17 | 121,558 | 4,390 | 13,073 | 2,278 |
| 30 Jun 17 | 118,874 | 5,681 | 13,713 | 1,948 |
| 31 Mar 17 | 119,791 | 6,049 | 12,900 | 2,631 |
| 31 Dec 16 | 124,361 | 7,227 | 12,969 | 2,584 |
| 30 Sep 16 | 126,960 | 7,140 | 12,024 | 2,370 |
| 30 Jun 16 | 133,602 | 9,064 | 11,862 | 2,370 |
| 31 Mar 16 | 140,885 | 10,722 | 12,870 | 1,615 |
| 31 Dec 15 | 144,639 | 11,480 | 12,066 | 2,149 |
| 30 Sep 15 | 144,658 | 10,458 | 11,732 | 2,251 |
| 30 Jun 15 | 142,814 | 8,926 | 11,288 | 2,251 |
| 31 Mar 15 | 138,104 | 7,263 | 10,585 | 2,158 |
| 31 Dec 14 | 131,566 | 5,825 | 9,941 | 2,064 |
| 30 Sep 14 | 122,795 | 3,908 | 9,268 | 1,947 |
| 30 Jun 14 | 117,809 | 2,871 | 9,006 | 1,947 |
| 31 Mar 14 | 112,091 | 795 | 9,178 | 2,160 |
| 31 Dec 13 | 108,178 | -1,311 | 8,906 | 2,504 |
Quality Earnings: A024890 is currently unprofitable.
Growing Profit Margin: A024890 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A024890 is unprofitable, and losses have increased over the past 5 years at a rate of 58.9% per year.
Accelerating Growth: Unable to compare A024890's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A024890 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.1%).
Return on Equity
High ROE: A024890 has a negative Return on Equity (-30.62%), as it is currently unprofitable.